rh-Endostatin相关论文
Preliminary results of a phase Ⅱ trial with continuous intravenous infusion rh-Endostatin plus dacar
目的： A phase Ⅱ study has revealed that rh-Endostatin (Endostar) was more effective when combining with dacarbazine ......
Objective: The aim of this study was to compare effect of rh-endostatin on microvasculature in tumor and myocardium tiss......
Objective: The aim of our study was to explore the inhibition and apoptosis-inducing effect of the combination of Huaier......
Perioperative rh-endostatin with chemotherapy improves the survival of conventional osteosarcoma pat
Objective:Anti-angiogenic drugs are an emerging treatment option against malignant tumors.The aim of this study was to d......
RH-ENDOSTATIN PLUS GEMCITABINE/NAVELBINE AND CISPLATIN AS FIRST-LINE TREATMENT PROTOCOL FOR NON-SMAL
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
Objective: The aim of this study was to compare effect of rh-endostatin on microvasculature in tumor and myocardium tiss......
Clinical observation of rh-endostatin combined with chemotherapy as first line treatment for metasta
Objective To analyze the efficacy and safety of Rh-endostatin combined with chemotherapy in the treatment of metastatic ......
Animal study of rh-endostatin combined with ginsenoside Rg3 on inhibiting growth of breast cancer xe
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
目的 观察重组人血管内皮抑制素对小鼠肿瘤及心肌中微血管影响的差异.方法 40只小鼠随机分为空白对照组(未荷瘤,生理盐水100 μl/d......
重组人血管内皮抑素(rh-Endostatin,rh-ES)是经国家食品药品监督管理局(SFDA)批准上市的我国自主研发的一种新型靶向抗血管生成药......
这研究的目的是在肿瘤和心肌层织物在微脉管系统上比较 rh-endostatin 的效果的目的。...
目的新型重组人血管内皮抑制素（rh-endostatin）的Ⅰ期、Ⅱ期、Ⅲ期临床试验证明该药临床应用安全有效。本研究旨在评价rh-endostatin......
为了获得高效表达分泌型重组人Endostatin菌株 ,利用基因工程技术 ,将目的基因连接到Pichia表达载体 pPIC9K中 ,将该重组质粒转入G......
Objective: The aim of our study was to explore the inhibition and apoptosis-inducing effect of the combination of Huaier......
目的：观察重组人血管内皮抑制素（rh—endostatin，商品名：恩度，endostar）的抗肿瘤及抗血管生成效应，比较其对移植瘤、心肌及肾脏组织中神经......
目的：探讨重组人血管内皮抑制素治疗瘢痕疙瘩的有效性及安全性。方法：将2015年1月-2016年1月在南充市中心医院就诊的瘢痕疙瘩患者64......
目的评价重组人血管内皮抑制素联合长春瑞滨+顺铂方案(NPE)治疗晚期非小细胞肺癌(NSCLC的疗效和安全性。方法使用计算机检索PubMed......
目的探讨奥沙利铂联合恩度在未切除的原发肝癌介入治疗中的疗效及不良反应。方法回顾性收集原发肝癌患者99例，其中48例灌注奥沙利铂......
目的探讨化疗联合重组人血管内皮抑素(恩度)治疗ⅡB期骨肉瘤的远期疗效及安全性。方法收集2008年1月至2012年4月北京积水潭医院骨......
目的:利用Pichia pastoris菌株高效表达重组人内皮细胞生长抑制因子(rh-Endostatin),并将其纯化至均质.方法:将构建的菌种Pichia p......
目的评价重组人血管内皮抑制素（恩度）联合化疗方案与单纯化疗治疗非小细胞肺癌疗效。方法收集2000~2009年有关恩度联合化疗方案治疗......
